Articles

These are the stocks to sell if you want to avoid companies that continue to produce losses and destroy investor capital. More

Some of the most explosive opportunities can be found in biotech stocks. In fact, as we head into New Year 2024, here are three to consider. More

Mullen will hold its special meeting of stockholders on Dec. 15. Shareholders of MULN stock can vote toward a reverse split proposal. More

Lexeo Therapeutics just reported results for the third quarter of 2023. More

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. More

The EV market is getting crowded and some companies are going out of business. Here are the three EV stocks to sell. More

Pasithea Therapeutics stock is climbing higher with heavy trading of KTTA shares alongside results from two preclinical trials. More

Subscriber Sign in